Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Bestatin (Ubenimex): Aminopeptidase Inhibitor Guide
2026-08-24
Bestatin, also called Ubenimex, is a research inhibitor of aminopeptidase B, leucine aminopeptidase, aminopeptidase N, and related cytosolic aminopeptidases. Its reported nanomolar-to-micromolar IC50 values support aminopeptidase activity measurement, apoptosis assay design, multidrug resistance (MDR) research, and cancer research, but assay conditions and translational limits must be defined.
-
Astrocytic GAT-3 in Dentate Gyrus Memory
2026-08-23
The reference study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission rather than a passive GABA-clearance mechanism. By linking GABA uptake to astrocytic Ca2+ signaling, presynaptic GluN2B-containing NMDARs, and contextual fear memory, it provides a mechanistic framework for studying glia-dependent plasticity in hippocampal circuits.
-
nor-Binaltorphimine Dihydrochloride Guide
2026-08-22
nor-Binaltorphimine dihydrochloride is a selective κ-opioid receptor antagonist for mechanistic opioid receptor signaling research. It provides a pharmacological way to interrogate KOR-linked pathways, but the 2024 mouse circuit study should not be treated as direct validation of this specific product.
-
Multiomics of Crossbreeding and Goose Meat Quality
2026-08-22
Huang et al. used transcriptomics and nontargeted metabolomics to examine how crossbreeding and sex shape production traits and breast-muscle biology in Xingguo gray geese. The study connects carcass and meat-quality phenotypes with gene-expression and metabolite changes, providing a framework for interpreting heterosis through integrated molecular data.
-
Metoprolol: Disease-Aware Beta1 Research Design
2026-08-21
Metoprolol is a selective beta1-adrenoceptor antagonist for mechanistic cardiovascular, inflammation, cancer, and angiogenesis research. This guide shows how disease-state pharmacokinetics and tissue exposure can improve assay design and interpretation.
-
BMAL1 Phosphorylation: From Condensates to Validation
2026-08-20
BMAL1 phase separation reframes phosphorylation as a spatial regulator of circadian transcription. This thought-leadership guide shows how Lambda Protein Phosphatase (RNase-free) can help translational researchers distinguish phosphorylation-dependent behavior from antibody artifacts, protein loss, or nonspecific changes in condensate assays.
-
CAMLs in Blood: Phenotype and Clinical Utility
2026-08-20
The reference study reframes circulating phagocytic polyploid giant cancer macrophages, or CAMLs, as biologically active cells rather than incidental tumor debris. In a two-year, multi-institutional prospective cohort of 293 patients with six solid tumor types, CAML abundance and phenotype were associated with progression and disease spread, supporting their investigation as blood-based indicators of metastatic biology.
-
Oligo (dT) 25 Beads for Immune-Cell RNA Discovery
2026-08-19
Oligo (dT) 25 Beads enable selective polyA tail mRNA capture for reproducible eukaryotic mRNA isolation. This article connects magnetic purification decisions with the single-cell immune profiling strategy used to study immune rejuvenation in an Alzheimer’s disease mouse model.
-
Losartan Workflows for Vascular and Renal Research
2026-08-19
Build reproducible Losartan assays for AT1 receptor biology, vascular smooth muscle cell proliferation inhibition, and hypertension research. This workflow also shows how to use Losartan as a mechanistically distinct comparator when adapting diabetic nephropathy findings to cardiovascular and renal models.
-
DiscoveryProbe Natural Product Library Plus
2026-08-18
DiscoveryProbe Natural Product Library Plus is a 1,655-compound natural product library supplied as 10 mM DMSO solutions for HTS and HCS workflows. Its documented formulation, NMR/HPLC quality checks, and defined storage conditions support reproducible screening, while Cryptosporidium AdhE research illustrates how library screening can generate antiparasitic hypotheses.
-
5X Protein Loading Buffer (Reducing) Guide
2026-08-18
5X Protein Loading Buffer (Reducing) standardizes protein sample preparation for conventional reducing SDS-PAGE by combining SDS-mediated denaturation, disulfide-bond reduction, and tracking dye. It is intended for molecular-weight-based separation and should not be used when native protein structure, disulfide connectivity, or non-reducing conditions must be preserved.
-
Phenothiazines, ROS, and Macrophage Autophagy
2026-08-17
A 2025 Frontiers in Immunology study shows that phenothiazines strengthen macrophage antibacterial activity through coordinated increases in lysosomal activity, autophagy, and reactive oxygen species. Inhibitor and scavenger experiments, together with perphenazine treatment in an in vivo Salmonella Typhimurium model, support a host-directed therapeutic framework for intracellular infections.
-
Betulinic Acid Protects Against Cyclophosphamide Liver Injur
2026-08-17
The reference study identifies an ERK-linked mitochondrial apoptotic pathway as a major contributor to cyclophosphamide-induced oxidative liver damage in mice. Its use of betulinic acid together with PD98059-based pathway interrogation connects NRF2 antioxidant defense, MAPK signaling, mitochondrial dynamics, and hepatocyte apoptosis.
-
Promethazine HCl: Designing Mechanism-First Assays
2026-08-16
Promethazine HCl is a versatile research probe for connecting H1 receptor biology with macrophage ROS, autophagy, and antibacterial activity. This guide presents a mechanism-first assay strategy that separates host-directed effects from direct antimicrobial activity and improves interpretation in immunology research.
-
Ivermectin Workflow for Parasitology Research
2026-08-15
Build reproducible Ivermectin screens around solvent-controlled dosing, parasite motility, viability, and orthogonal confirmation. This workflow also shows how a pancreatic cancer study can inspire better phenotype-versus-mechanism assay design without implying an oncology use for ivermectin.